|Bid||234.30 x 0|
|Ask||234.80 x 0|
|Day's range||232.70 - 235.50|
|52-week range||166.50 - 245.40|
|Beta (5Y monthly)||0.40|
|PE ratio (TTM)||27.77|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Here is how Swedish Orphan Biovitrum (BIOVF) and EDAP TMS S.A. (EDAP) have performed compared to their sector so far this year.
Swedish Orphan Biovitrum (BIOVF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Apellis' (APLS) earnings missed estimates in the first quarter of 2022, while revenues surpassed expectations.